Photostability-indicating HPLC method for determination of trifluoperazine in bulk form and pharmaceutical formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 11, 1996, Pages 1639-1644

  Abdel Moety, Ezzat M ^a   Al Rashood, Khalid A ^a   Rauf, A ^a,b   Khattab, Nashaat A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Determination; HPLC; Photochemistry; Stability indication; Tablets; Trifluoperazine

Indexed keywords

TRIFLUOPERAZINE;

ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTODEGRADATION; PRIORITY JOURNAL; TABLET; TECHNIQUE;

EID: 0030217956     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(96)01778-5     Document Type: Article

References (35)

1. [1] G.M.J. Beijersbergen van Henegouwen, Photochemistry of drugs in vivo and in vitro; in D.D. Breimer and P. Speiser (Eds.), Topics in Pharmaceutical Sciences, Elsevier/North-Holland Biomedical Press, Amsterdam, 1981, pp. 235-256.
2. [2] L.C. Harber and R.L. Baer, J. Invest. Dermatol., 58 (1972) 327-342.
3. [3] R.L. Baer and L.C. Harber, J. Am. Med. Assoc., 192 (1965) 147.
4. [4] E. Stempel and R. Stempel, J. Am. Pharm. Assoc., NS13 (1973) 200-204.
5. [5] M.M. Mathews-Roth, Photochem. Photobiol., 22 (1975) 302.
6. [6] D.E. Moore, J. Pharm. Sci., 66 (1977) 1282-1284.
7. [7] W.M.D. Stewart, J.L. Danto and S. Maddin (Eds.), Dermatology: Diagnosis and treatment of cutaneous disorders, 3rd edn., The C.V. Mosby Co., St. Louis, MO, 1974, p. 324.
8. [8] A. Felmeister and C.A. Discher, J. Pharm. Sci., 53 (1964) 756-762.
9. [9] I.S. Forrest, P.M. Forrest and M. Berger, Biochim. Biophys. Acta, 29 (1958) 441-442.
10. [10] C.L. Huang and F.L. Sands, J. Pharm. Sci., 56 (1967) 259-262.
11. [11] F.W. Grant, in I.S. Forrest, C.J. Carr and E. Usdin (Eds.), The Phenothiazines and Structurally Related Drugs; Raven Press, New York, 1974 p. 539.
12. [12] J.B. Bagland and V.J. Kinross-Wright, Anal. chem., 36 (1964) 1356-1359.
13. [13] F.J. Mellinger and C.E. Keeler, Anal. Chem., 35 (1963) 554-558.
14. [14] F.J. Mellinger and C.E. Keeler, Anal. Chem., 36 (1964) 1840-1847.
15. [15] V.R. White, C.S. Frings, J.E. Villafranca and J.M. Fritzgerald, Anal. Chem., 48 (1976) 1314-1316.
16. [16] M.A. Koupparis and A. Barcuchova, Analyst, 111 (1986) 313-318.
17. [17] S.M. Sultan, Micorchem. J., 44 (1991) 304.
18. [18] J. Martinez Calatayud and V. Garcia Mateo, Anal. Chim. Acta, 264 (1992) 283.
19. [19] J. Martinez Calatayud and T. Garcia Sancho, J. Pharm. Biomed. Anal., 10 (1992) 37-42.
20. [20] T. Pérez-Ruiz, C. Martinez-Lozano, V. Tomás and C. Sidrach De Cardona, Talanta, 40 (1993) 1361-1365.
21. [21] D. Chen, A. Rios, M.D. Luque de Castro and M. Valcarcel, Analyst, 116 (1991) 171.
22. [22] J. Martinez Calatayud and C. Gomez Benito, Anal. Chim. Acta, 256 (1992) 105-111.
23. [23] M.T. Tena, M.D. Luque de Castro and M. Valcarcel, J. Automat. Chem., 13 (1991) 11-14.
24. [24] D. Chen, A. Rios, M.D. Luque de Castro and M. Valcarcel, Talanta, 11 (1991) 1227-1233.
25. [25] I. Jane, A. Mickinnon and R.J. Flanagan, J. Chromatogr., 323 (1985) 191-225.
26. [26] W.T. Kok, W.H. Voogt, U.A.T. Brinkman and R.W. Frei, J. Chromatogr., 354 (1986) 249-257.
27. [27] S. Li and W.C. Purdy, J. Pharm. Biomed. Anal., 9 (1991) 409-415.
28. [28] D. Sharples, J. Pharm. Pharmacol., 33 (1981) 242-243.
29. [29] D.J. Cavanaugh, Science, 125 (1957) 1040-1042.
30. [30] L.H. Piette, G. Bullow and I. Yamazaki, Biochim. Biophys. Acta, 88 (1964) 120-123.
31. [31] A. Felmeister and C.A. Dishe, J. Pharm. Sci., 53 (1964) 756-759.
32. [32] T.N. Pradas and M. Sivakumar, Pharmazie, 47 (1992) 231.
33. [33] E.G. Levering, N. Bequlieu, R.C. Lawrence and R.W. Sears, J. Assoc. Off. Anal. Chem., 68 (1985) 168-171.
34. [34] S.M. Desai, J.M. Khatri and J.K. Lalla, Indian Drugs, 27 (1990) 389-391.
35. [35] J.E. Kountourellis, C.K. Markopoulou and J.A. Stratis, Anal. Lett., 26 (1993) 2171-2182.